Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-06-10

FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lamotrigine from Zydus Pharmaceuticals USA Inc., signaling a labeling change or addition to the product's approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)